Case Report
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Feb 15, 2025; 17(2): 100724
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.100724
Figure 2
Figure 2 Imaging changes in liver metastasis in the patient receiving different anticancer regimens. Following treatment with camrelizumab in combination with apatinib, enhanced abdominal magnetic resonance imaging revealed no increase in size or enhancement of the liver metastasis.